… The Michael J. Fox Foundation for Parkinson’s Research today announced the 2008 launch of its annual Clinical … and technically challenging but are often hampered by budgetary constraints that can limit the quality and quantity … duration, etc.). Applicants should make a strong case for how the additional information can significantly improve the …

… of movement.  Unfortunately the onset of these clinical symptoms may not occur until after loss of a substantial amount … in the brain. Identification of a biomarker could lead to earlier diagnosis, and thereby earlier intervention. The … need of robust drug efficacy markers. Anticipated Outcome: Lead biomarker candidates identified in this study may …

…  released their sixth annual list of the "World's Greatest Leaders," an impressive group of 50 women and men in … arts who are transforming the world and inspiring others to do the same. Listed at 22, Michael J. Fox is honored for … on our mission to cure Parkinson's by joining our community.  Sign up for access  to breaking news emails, …

… from a prior grant: Delivery of Kinase-Modified LRRK2 to Dopaminergic Neurons Using High-Capacity Viral Vectors Promising Outcomes of Original Grant: Mutations in LRRK2 are the most … validate LRRK2 kinase activity as an appropriate target for disease therapeutics, create a new and robust model …

… Study Rationale: Dystonia and Parkinson's disease (PD) are closely related … people with PD experience dystonia as an early symptom or complication of treatment. Deep brain stimulation (DBS) is a … pulses are delivered to the brain. DBS may soon become a much-needed solution for dystonia in Parkinson's. In …

… Page Cancel Register for Webinar From Low Blood Pressure to Bladder Problems: A Look at Lesser-Known Parkinson’s … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … from the Michael J. Fox Foundation. Save my information for faster registration. Create a michaeljfox.org account by …